TIMEKIA THOMPSON: Open Payments
NPI 1326683558 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 61 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,556
Food & beverage: $1,556
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $340 |
| Teva Pharmaceuticals USA, Inc. | 10 | $318 |
| ABBVIE INC. | 12 | $311 |
| Neurocrine BioSciences, Inc. | 14 | $230 |
| Otsuka America Pharmaceutical, Inc. | 3 | $163 |
| Janssen Pharmaceuticals, Inc | 5 | $108 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, INGREZZA, ARISTADA, UZEDY, AUSTEDO XR, REXULTI, LYBALVI, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
